FR2852M - Pharmaceutical preparations acting on the central nervous system. - Google Patents

Pharmaceutical preparations acting on the central nervous system.

Info

Publication number
FR2852M
FR2852M FR927799A FR927799A FR2852M FR 2852 M FR2852 M FR 2852M FR 927799 A FR927799 A FR 927799A FR 927799 A FR927799 A FR 927799A FR 2852 M FR2852 M FR 2852M
Authority
FR
France
Prior art keywords
nervous system
central nervous
pharmaceutical preparations
preparations acting
acting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR927799A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Application granted granted Critical
Publication of FR2852M publication Critical patent/FR2852M/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR927799A 1962-03-14 1963-03-13 Pharmaceutical preparations acting on the central nervous system. Active FR2852M (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL275964 1962-03-14

Publications (1)

Publication Number Publication Date
FR2852M true FR2852M (en) 1964-10-19

Family

ID=19753670

Family Applications (1)

Application Number Title Priority Date Filing Date
FR927799A Active FR2852M (en) 1962-03-14 1963-03-13 Pharmaceutical preparations acting on the central nervous system.

Country Status (4)

Country Link
BE (1) BE629596A (en)
ES (1) ES285768A1 (en)
FR (1) FR2852M (en)
GB (1) GB1041861A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0362941A2 (en) * 1988-10-07 1990-04-11 Merck Sharp & Dohme Ltd. 4-Methyl and 4-ethyl substituted pyrrolidin-2-ones

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727792D0 (en) * 1987-11-27 1987-12-31 Merck Sharp & Dohme Therapeutic agents
AU2003263393A1 (en) * 2002-09-04 2004-03-29 Glenmark Pharmaceuticals Limited New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
DE60317918T2 (en) 2002-10-23 2009-01-29 Glenmark Pharmaceuticals Ltd. TRICYCLIC COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISEASES METHOD OF PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEY
BRPI0409747A (en) 2003-04-11 2006-05-09 Glenmark Pharmaceuticals Sa novel heterocyclic compounds useful for treating inflammatory and allergic disorders, processes for their preparation and pharmaceutical compositions containing these
MX2007004400A (en) 2004-10-13 2007-06-19 Glenmark Pharmaceuticals Sa Process for the preparation of n-(3, 5-dichloropyrid-4-yl)-4 oromethoxy-8-methanesulfonamido-dibenzo [b, d] diflufuran-1-carboxamide.
DK1831227T3 (en) 2004-12-17 2013-08-19 Glenmark Pharmaceuticals Sa Hitherto unknown, heterocyclic compounds useful in the treatment of inflammatory and allergic disorders
WO2006064355A2 (en) 2004-12-17 2006-06-22 Glenmark Pharmaceuticals S.A. Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0362941A2 (en) * 1988-10-07 1990-04-11 Merck Sharp & Dohme Ltd. 4-Methyl and 4-ethyl substituted pyrrolidin-2-ones
EP0362941A3 (en) * 1988-10-07 1991-11-06 Merck Sharp & Dohme Ltd. 4-Methyl and 4-ethyl substituted pyrrolidin-2-ones

Also Published As

Publication number Publication date
GB1041861A (en) 1966-09-07
ES285768A1 (en) 1963-07-01
BE629596A (en) 1963-10-21

Similar Documents

Publication Publication Date Title
FR2973M (en) Alpha-aminoketone.
FR2513M (en) Anti-inflammatory preparations.
DK107636C (en) Syringe.
FR3041M (en) Vitamin preparations.
FR2852M (en) Pharmaceutical preparations acting on the central nervous system.
DK112125B (en) Falstagsten.
FR2526M (en) Pyrocatechol-0-methyltransferase inhibitor drug.
DK105974C (en) Lastpallemagasin.
DK113877B (en) Central extraction unit.
FR2033M (en) New drug acting on the central nervous system.
FR2519M (en) Analgesic drug.
DK102997C (en) Acaricide.
FR1984M (en) Neuropsychic regulator drug.
FR2456M (en) Hemotherapic drug.
DK106209C (en) Casting sleeve.
FR2894M (en) Phenylalkanolamine.
DK103099C (en) Plov.
FR1828M (en) Spasmolytic drug.
FR134M (en) New drug acting on the central nervous system.
FR2698M (en) Anti-thyroid drug.
ES90836Y (en) PERFECTED GIRDLE-PANTIES.
FR1296M (en) Vitamin action drug p.
NL141288B (en) GUIDED SYSTEM.
BE618332A (en) Seat.
NL143396B (en) WRITE-WRITE CONNECTION SYSTEM.